Investor Type | Firm |
Type of Fund | Venture Capital Fund |
Industries | IT (& TMT) • BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Oncology |
Stages | Expansion |
Investing | United States • Israel • Europe |
Investment Range | $68,000,000 - $68,000,000 |
Canepa Healthcare, now known as Evidity Health Capital, is a venture capital and growth equity firm dedicated to investing in late-stage healthcare companies predominantly within the United States and Europe. Since its inception in 2014, the firm, with offices in both New York and Miami, has focused on the healthcare industry, pooling expertise in equity investments specifically in the fields of IT, BioTech, HealthTech and Fitness, Medical Devices and Hospital Services, and Oncology. With a specialization in expansion, Evidity Health Capital is geared towards businesses that have already commercialized their products and are in pursuit of growth capital to drive profitability. The fund's sizeable investment of 68 million USD reflects its commitment to empowering companies that exhibit significant potential for advancement and innovation in healthcare. Emphasizing a value-focused and evidence-based strategy, their approach helps businesses develop and ultimately aims to aid in improving patient outcomes through a thoughtful and impactful allocation of resources. Their investment philosophy is deeply rooted in strong business-building capabilities, ensuring the firms they partner with benefit from robust growth and promising profitability trajectories. Evidity Health Capital's asset management includes a portfolio of leading, innovative, and transformative healthcare companies, with a track record that underscores their proficiency in recognizing and nurturing excellence within the healthcare sector.